First Time Loading...

GenMont Biotech Inc
TWSE:3164

Watchlist Manager
GenMont Biotech Inc Logo
GenMont Biotech Inc
TWSE:3164
Watchlist
Price: 24.5 TWD 0.2% Market Closed
Updated: Jun 16, 2024
Have any thoughts about
GenMont Biotech Inc?
Write Note

Gross Margin
GenMont Biotech Inc

66.8%
Current
68%
Average
63.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
66.8%
=
Gross Profit
237m
/
Revenue
354.8m

Gross Margin Across Competitors

Country TW
Market Cap 2.1B TWD
Gross Margin
67%
Country US
Market Cap 297.7B USD
Gross Margin
66%
Country US
Market Cap 160.2B USD
Gross Margin
66%
Country US
Market Cap 124.2B USD
Gross Margin
87%
Country US
Market Cap 114.2B USD
Gross Margin
86%
Country AU
Market Cap 139.1B AUD
Gross Margin
52%
Country US
Market Cap 81.1B USD
Gross Margin
76%
Country US
Market Cap 53.6B USD
Gross Margin
22%
Country US
Market Cap 43.1B USD
Gross Margin
75%
Country US
Market Cap 33.7B USD
Gross Margin
75%
Country KR
Market Cap 38T KRW
Gross Margin
47%

Profitability Report

View the profitability report to see the full profitability analysis for GenMont Biotech Inc.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
66.8%
=
Gross Profit
237m
/
Revenue
354.8m
What is the Gross Margin of GenMont Biotech Inc?

Based on GenMont Biotech Inc's most recent financial statements, the company has Gross Margin of 66.8%.